Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Visit

ASH 2023 | Improving the sensitivity of platelet autoantibody testing for ITP diagnosis

Hanny Al-Samkari • 9 Dec 2023

ASH 2023

Immune Thrombocytopenia Non-Malignant

Hanny Al-Samkari, MD, Massachusetts General Hospital, Boston, MA, describes the current challenges in platelet autoantibody testing in immune thrombocytopenia (ITP). Currently, there is no gold standard diagnostic test for ITP, with platelet autoantibody testing having low sensitivity due to difficulties separating a positive signal from background noise. New techniques have emerged to improve the efficacy of this testing and provide a potential use in the prognosis of ITP. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Emerging treatment options for refractory immune thrombocytopenia

Hanny Al-Samkari • 9 Dec 2023

Mitapivat improves work/school attendance in patients with pyruvate kinase deficiency

Hanny Al-Samkari • 9 Dec 2023

Avatrombopag in patients with early versus chronic immune thrombocytopenia

Hanny Al-Samkari • 9 Dec 2023

The role of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia

Hanny Al-Samkari • 25 Jun 2023

Related Videos

The MDT in the new era of gene therapy for hemoglobinopathies

Mattia Algeri • 15 Apr 2024

Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases

Rita Beier • 15 Apr 2024

A global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs

Ali Taher • 15 Apr 2024

The future of CAR T-reg cells: organ transplantation & autoimmune disease

Zinaida Good • 9 Apr 2024